Perillyl alcohol and its synthetic derivatives: the rising of a novel class of selective and potent antitumoral compounds.

Bibliographic Details
Title: Perillyl alcohol and its synthetic derivatives: the rising of a novel class of selective and potent antitumoral compounds.
Authors: Lessa, Renato C. S., Gomes, Aline C. C. A.
Source: Medicinal Chemistry Research; May2022, Vol. 31 Issue 5, p677-694, 18p
Abstract: (S)-(-)-perillyl alcohol (POH) is a natural occurrence monoterpene that can be found in specific plants' essential oil. Despite its poor bioavailability when orally administered, due to fast metabolization through P450 enzyme oxidation, inhalation unveiled its selective cytotoxicity for glioma cells. Actually, under phase I/II clinical trial for glioblastoma multiforme (GBM) treatment at Hospital Universitário Antônio Pedro (HUAP) in Brazil, POH became a potential lead compound for developing novel antitumoral drugs. Recent reports highlight POH potential as a chemosensitizing agent, describes efficient novel derivatives for topical administration in multiple myeloma treatment and unveils its effectivity against different chemoresistant cancer cell lines. In this review, POH and its synthetical derivatives will be presented reporting its potential as a valuable scaffold to develop novel selective antitumoral agents. A summarized biological and mechanistic approach is also discussed. Only selected synthetic procedures are presented to keep the article in a reader-friendly fashion. [ABSTRACT FROM AUTHOR]
Copyright of Medicinal Chemistry Research is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:10542523
DOI:10.1007/s00044-022-02870-6
Published in:Medicinal Chemistry Research
Language:English